Palbociclib combined with endocrine treatment in breast cancer patients with high relapse risk after neoadjuvant chemotherapy: Subgroup analyses of premenopausal patients in PENELOPE-B.

Frederik  Marmé

No Relationships to Disclose

Miguel  Martin

Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech

Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; PharmaMar; Roche/Genentech; Taiho Pharmaceutical

Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech

Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)

Other Relationship - Novartis; Roche

Michael  Untch

Honoraria - Agendia (Inst); Art tempi (Inst); AstraZeneca (Inst); Bristol Myer Squibb (Inst); Celgene (Inst); Daiji Sankyo (Inst); MSD Oncology (Inst); Mundipharma (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche Pharma AG (Inst); Sanofi (Inst); Seagen (Inst)

Consulting or Advisory Role - Abbvie (Inst); Agendia (Inst); Amgen (Inst); Celgene (Inst); Lilly (Inst); MSD Oncology (Inst); Mundipharma (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche Pharma AG (Inst); Seagen (Inst)

Herve R.  Bonnefoi

Honoraria - Roche

Research Funding - Bayer (Inst)

Travel, Accommodations, Expenses - Pfizer; Roche

Sung-Bae  Kim

Honoraria - DAEHWA Pharmaceutical; ISU ABXIS

Consulting or Advisory Role - AstraZeneca; DAEHWA Pharmaceutical; ISU Abxis; Lilly (Inst)

Research Funding - Dongkook Pharma (Inst); Genzyme (Inst); Novartis (Inst)

Harry Douglas  Bear

Stock and Other Ownership Interests  - Abbvie; Pfizer; Viatris

Honoraria - Genomic Health; Merck

Consulting or Advisory Role - Merck; RNADx

Speakers' Bureau - Genomic Health

Research Funding - Merck

Travel, Accommodations, Expenses - Merck

Nicole  Mc Carthy

No Relationships to Disclose

Karen A.  Gelmon

Honoraria - AstraZeneca; Merck Sharp & Dohme; Novartis Canada Pharmaceuticals Inc; Seagen

Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Bristol-Myers Squibb; Genomic Health; Janssen Oncology; Lilly; Merck; Mylan; NanoString Technologies; Novartis; Pfizer; Roche

Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche (Inst)

Expert Testimony - Genentech

José A.  García-Sáenz

Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Lilly; MSD; Novartis; Pfizer; Seagen

Research Funding - AstraZeneca

Travel, Accommodations, Expenses - Novartis; Pfizer; Roche

Catherine Margaret  Kelly

Honoraria - Daiichi Sankyo Europe GmbH; Exact Sciences; MSD Oncology; Novartis; Pfizer; Roche

Travel, Accommodations, Expenses - pfizer; Roche

Toralf  Reimer

Honoraria - Lilly; Novartis; Pfizer

Consulting or Advisory Role - Novartis; Pfizer

Masakazu  Toi

Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Devicor Medical Products; Eisai; Exact Sciences; Konica Minolta; Kyowa Kirin; Lilly; Nippon Kayaku; Novartis; Pfizer; Shimadzu; Taiho Pharmaceutical; TAKEDA; Yakult Pharmaceutical

Consulting or Advisory Role - AstraZeneca; Athenex; Bertis; BMS; Daiichi Sankyo; Kansai Medical; Kyowa Kirin; Lilly; Lux Biosciences; Lux Biosciences; Terumo

Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Lilly; Pfizer

Research Funding - AFI technology; Astellas Pharma; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Japan Breast Cancer Research Group; Kyoto Breast cancer Research Network; Nippon Kayaku; Ono Pharmaceutical; Pfizer; Shimadzu; Taiho Pharmaceutical

Patents, Royalties, Other Intellectual Property - JP 2017-143763 WO2017/131162A1 (Inst); PCT/JP2016/004374 (Inst)

Travel, Accommodations, Expenses - Eisai; Takeda

Other Relationship - Japan Breast Cancer Research Group; Kyoto Breast Cancer Research Network; Organization for Oncology and Translational Research

Hope S.  Rugo

Honoraria - Mylan; Puma Biotechnology

Consulting or Advisory Role - Samsung

Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)

Travel, Accommodations, Expenses - AstraZeneca Spain; Daiichi Sankyo; Macrogenics; Merck; Mylan; Novartis; Pfizer

Michael  Gnant

Employment - Sandoz (I)

Honoraria - Amgen; AstraZeneca; Lilly; Novartis

Consulting or Advisory Role - Daiichi-Sankyo; LifeBrain; Lilly; Tolmar; Veracyte

Andreas  Makris

Honoraria - Lilly; NanoString Technologies; Pfizer; Roche

Consulting or Advisory Role - Lilly; Pfizer; Roche

Speakers' Bureau - Lilly; NanoString Technologies; Pfizer; Roche

Travel, Accommodations, Expenses - Roche

Mariajose  Lechuga

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Sabine  Seiler

Stock and Other Ownership Interests  - Roche (I)

Consulting or Advisory Role - Amgen; Mundipharma

Travel, Accommodations, Expenses - Novartis

Fenja  Seither

No Relationships to Disclose

Sibylle  Loibl

Honoraria - Chugai Pharma

Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); EirGenix (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Lilly (Inst); Medscape (Inst); Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Puma Biotechnology (Inst); Roche (Inst); Samsung (Inst); Seagen (Inst)

Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Immunomedics (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)

Patents, Royalties, Other Intellectual Property - Patent Pending EP14153692.0 (Inst)